Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 111-120 of 150 for Ovarian

Edit search filters
  1. Patient Experience and Understanding of Genetic Testing in Ovarian Cancer

    Rochester, MN

  2. Improving Genetic Referral Rates in Women with Ovarian Cancer

    Rochester, MN

  3. A Study to Evaluate Regulation of the Metabolism of T-Cells by the Tumor Microenvironment in Ovarian Cancer Metastasis

    Scottsdale/Phoenix, AZ

  4. Ovarian Cancer Microbiome Signatures

    Rochester, MN

  5. Ovarian and Uterine Cancer Patients' Cancer Diagnosis and Treatment-Related Characteristics from Medical Records

    Rochester, MN

  6. A Study to Evaluate Immune Response Changes to Ovarian Cancer During Chemotherapy

    Rochester, MN

  7. A Study to Evaluate the Venn Ovarian CAncer Liquid Biopsy

    Jacksonville, FL

  8. A Novel Method of Screening for Ovarian Cancer Using Gynecologic Fluids and Mucus

    Rochester, MN

  9. DNA Damage Using hERY-MNT Technology can Predict Chemotherapy Induced Toxicity in Women with Ovarian Cancer

    Rochester, MN

  10. Biospecimen Resource for Ovarian Cancer Research

    Scottsdale/Phoenix, AZ, Rochester, MN

.

Mayo Clinic Footer